PATL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. PATL Gen Silencer sind erhältlich als PATL CRISPR/Cas9 Knockout Plasmide und PATL Double Nickase Plasmide. PATL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
PATL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PATL1 CRISPR/Cas9 KO Plasmid (h) | sc-415098 | h | Gene Knockout | GFP | 0 | ||
PATL1 HDR Plasmid (h) | sc-415098-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PATL1 Double Nickase Plasmid (h) | sc-415098-NIC | h | Gene Knockout | Puromycin | 0 | ||
PATL1 Double Nickase Plasmid (h2) | sc-415098-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PATL1 CRISPR/Cas9 KO Plasmid (m) | sc-432579 | m | Gene Knockout | GFP | 0 | ||
PATL1 HDR Plasmid (m) | sc-432579-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PATL1 Double Nickase Plasmid (m) | sc-432579-NIC | m | Gene Knockout | Puromycin | 0 | ||
PATL1 Double Nickase Plasmid (m2) | sc-432579-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PATL2 CRISPR/Cas9 KO Plasmid (h) | sc-418821 | h | Gene Knockout | GFP | 0 | ||
PATL2 HDR Plasmid (h) | sc-418821-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PATL2 Double Nickase Plasmid (h) | sc-418821-NIC | h | Gene Knockout | Puromycin | 0 | ||
PATL2 Double Nickase Plasmid (h2) | sc-418821-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PATL2 CRISPR/Cas9 KO Plasmid (m) | sc-426635 | m | Gene Knockout | GFP | 0 | ||
PATL2 HDR Plasmid (m) | sc-426635-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PATL2 Double Nickase Plasmid (m) | sc-426635-NIC | m | Gene Knockout | Puromycin | 0 | ||
PATL2 Double Nickase Plasmid (m2) | sc-426635-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PATL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PATL1 CRISPR Activation Plasmid (h) | sc-415098-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 CRISPR Activation Plasmid (h2) | sc-415098-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 Lentiviral Activation Particles (h) | sc-415098-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 Lentiviral Activation Particles (h2) | sc-415098-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 CRISPR Activation Plasmid (m) | sc-432579-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 CRISPR Activation Plasmid (m2) | sc-432579-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 Lentiviral Activation Particles (m) | sc-432579-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL1 Lentiviral Activation Particles (m2) | sc-432579-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 CRISPR Activation Plasmid (h) | sc-418821-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 CRISPR Activation Plasmid (h2) | sc-418821-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 Lentiviral Activation Particles (h) | sc-418821-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 Lentiviral Activation Particles (h2) | sc-418821-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 CRISPR Activation Plasmid (m) | sc-426635-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 CRISPR Activation Plasmid (m2) | sc-426635-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 Lentiviral Activation Particles (m) | sc-426635-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PATL2 Lentiviral Activation Particles (m2) | sc-426635-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |